Randomized study of the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval in healthy subjects

AIMS: We investigated the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval at clinical and supraclinical dose, considering the relative hyperosmolarity of this product. METHODS: This was a single centre, randomized, double‐blind, placebo‐ and positive‐controlled, 4‐...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Clin Pharmacol
Autori principali: Funck‐Brentano, Christian, Felices, Mathieu, Le Fur, Nathalie, Dubourdieu, Corinne, Desché, Pierre, Vanhoutte, Frédéric, Voiriot, Pascal
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576613/
https://ncbi.nlm.nih.gov/pubmed/32302009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14309
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi